Form 4: NeuroMetrix CFO Thomas Higgins Reports Stock Transactions
SEC Form 4 Filing
Thomas Higgins, CFO of NeuroMetrix, Inc., reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On November 2, 2023, Thomas Higgins, the CFO of NeuroMetrix, Inc., reported transactions involving the company's common stock.
- These transactions included the vesting of 3,983 restricted stock units at a price of $3.8424 per share.
- 430 shares were withheld to cover withholding taxes related to the vesting of these units.
- Following these transactions, Higgins directly owns 57,789 shares of NeuroMetrix common stock and 23,896 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions, so the sentiment is neutral.
Industry Context
This is a standard SEC Form 4 filing, which is common for corporate insiders reporting transactions in their company's stock. It provides transparency into the trading activities of key personnel.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| May 24, 2022 | Reporting person was granted 47,794 restricted stock units, which vest in equal quarterly installments over three years beginning on August 2, 2022. |
| August 2, 2022 | Vesting of restricted stock units began in equal quarterly installments over three years. |
| November 2, 2023 | Date of transactions reported: vesting of restricted stock units and tax withholding. |
| March 6, 2024 | Date of signature for the Form 4 filing. |
Keywords
NeuroMetrix, NURO, Thomas Higgins, CFO, Form 4, Restricted Stock Units, Vesting, Beneficial Ownership, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.